Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a type of brain tumour called glioma, confirmed through tissue testing
- People who have a complete set of MRI scans with clear, usable images
- People who have signed a form agreeing to take part in the study
Who may not be able to join:
- People who have other neurological (brain or nervous system) conditions
- People who have already had surgery, a biopsy, radiation therapy, or chemotherapy before joining the trial
- People who are unable to complete the required clinical assessments, lab tests, or follow-up appointments
- People who are unable to have an MRI scan, or whose MRI images are of poor quality due to movement or other issues
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yaou Liu, Doctor, Beijing Tiantan Hospital
Phone: +86 1059975396
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Establish standardized clinical-MRI-molecular markers database for CNS tumors; Establish prospective brain tumor cohort with multiomics information
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.